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ABSTRACT
Background: Small-quantity lipid-based nutrient supplements (SQ-
LNS) are efficacious in controlled settings; data are scarce on the
effectiveness utilizing health care delivery platforms.
Objective: We evaluated the impact of an infant young child feeding
(IYCF)–SQ-LNS intervention on anemia and growth in children aged
6–18 mo in the Democratic Republic of Congo following a quasi-
experimental effectiveness design.
Methods: An intervention health zone (HZ) received enhanced IYCF
including improved counseling on IYCF during pregnancy until 12
mo after birth and daily use of SQ-LNS for infants 6–12 mo; the
control HZ received the standard IYCF package. We analyzed data
from 2995 children, collected in repeated cross-sectional surveys. We
used adjusted difference-in-difference analyses to calculate changes
in anemia, iron and vitamin A deficiencies, stunting, wasting, and
underweight.
Results: Of mothers, 70.5% received SQ-LNS at least once in the
intervention HZ, with 99.6% of their children consuming SQ-LNS
at least once. The mean number of batches of SQ-LNS (28 sachets
per batch, 6 batches total) received was 2.3 ± 0.8 (i.e., 64.4 ± 22.4 d
of SQ-LNS). The enhanced program was associated with an 11.0%
point (95% CI: −18.1, −3.8; P < 0.01) adjusted relative reduction
in anemia prevalence and a mean +0.26-g/dL (95% CI: 0.04, 0.48;
P = 0.02) increase in hemoglobin but no effect on anthropometry
or iron or vitamin A deficiencies. At endline in the intervention
HZ, children aged 8–13 mo who received ≥3 monthly SQ-LNS
batch distributions had higher anthropometry z scores [length-for-
age z score (LAZ): +0.40, P = 0.04; weight-for-age z score (WAZ):
+0.37, P = 0.04] and hemoglobin (+0.65 g/dL, P = 0.007) and a
lower adjusted prevalence difference of stunting (−16.7%, P = 0.03)
compared with those who received none.
Conclusions: The enhanced IYCF–SQ-LNS intervention using the
existing health care delivery platform was associated with a reduction
in prevalence of anemia and improvement in mean hemoglobin.
At endline among the subpopulation receiving ≥3 mo of SQ-LNS,
their LAZ, WAZ, and hemoglobin improved. Future research could
explore contextual tools to maximize coverage and intake adherence
in programs using SQ-LNS. Am J Clin Nutr 2020;112:683–694.
Keywords: effectiveness, quasi-experiment, integrated IYCF-SQ-
LNS, child growth, micronutrients
Introduction
Stunting and anemia are major public health issues globally.
More than 150 million children <5 y of age suffer from
stunted linear growth (1). At the individual level, anemia and
stunting can adversely affect cognitive development, immunity,
and overall nutritional status during the critical period from
conception to 2 y of age (2–4). As a result, it is a priority to
identify interventions to reduce anemia and stunting that can be
effectively implemented by local health systems, governments,
and international organizations (2, 5).
To optimize healthy growth and development of young
children, it is recommended that infant and young child feeding
(IYCF) practices include immediate initiation of breastfeeding,
exclusive breastfeeding for the first 6 mo of life, and the
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introduction of micronutrient-rich, age-appropriate foods starting
at 6 mo of age. A randomized controlled trial (RCT) of nutrition
education interventions to improve IYCF practices and delivered
through health services decreased stunting prevalence in Peruvian
children (6). While most countries have a standard care package
with counseling on IYCF (7, 8), guidance has been generic
and not context specific (9), which has contributed to lack of
impact on key indicators. Programs are implemented with large
gaps in coverage (10). In response to this, UNICEF introduced
the community-based IYCF counseling package in 2010, which
includes several planning, training, and counseling tools to
support programming and to strengthen the capacity of health
workers (11). Furthermore, in 2020, UNICEF published updated
programming guidance on improving young children’s diets
during the complementary feeding period (12, 13).
Over the past decade, home fortification interventions (also
known as point-of-use fortification) have gained recognition as
an efficacious approach for the prevention of anemia and other
micronutrient deficiencies (14). Multiple micronutrient powders
and small-quantity lipid-based nutrient supplements (SQ-LNS)
have been used to fill nutrient gaps and support healthy infant
growth and development (15, 16). For young children starting
at 6 mo of age, these products are intended to be mixed into
local complementary foods to increase the needed essential
nutrient composition of the local foods, which may not be
nutrient dense. SQ-LNS are single-serve sachets containing ≤20
g (≤120 kcal) of a paste typically containing peanuts, sugar,
vegetable fat, skimmed-milk powder, and vitamin and mineral
fortificants. The majority of studies on the impact of SQ-LNS on
child nutritional status have used randomized controlled designs
(17–20) reporting mixed overall associations on growth, while
others found beneficial impacts on hemoglobin and reductions in
anemia and iron deficiency (ID) (21, 22). It is noteworthy that
recent evaluations in programmatic contexts in Madagascar and
Bangladesh found a positive impact on iron biomarkers [ferritin
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and soluble transferrin receptor (sTfR)], anemia reduction, and
improvements in child growth and development (23, 24).
The need for wider exploration of an integrated IYCF–SQ-
LNS package within community health delivery platforms has
been suggested (25), but, to our knowledge, few large-scale
programs have attempted this, even though it might be an
effective nutrition intervention in resource-poor settings. Based
on comprehensive formative research (26), we conducted an
integrated community-based enhanced IYCF–SQ-LNS program
to evaluate the effectiveness on anemia, iron and vitamin A status,
and child growth indicators in children 6–18 mo of age from 2
health zones (HZs) within Katanga Province of the Democratic
Republic of Congo (DRC).
Methods
Setting and program context
The integrated IYCF–SQ-LNS program, known locally as the
IMIKA program, which stands for “Good Food for the Nourish-
ment of Infant and Young Children” (in Kiswahili), was piloted
in 1 HZ in the Katanga Province. The population estimate for the
HZ was 129,502 people with an estimated 2525 children aged 6–
12 mo. The province was selected for this pilot because the infant
and young child health characteristics were poor, but the province
was generally less affected by the political instability affecting
the rest of the country, which could have disrupted program im-
plementation. The intervention and control HZs were in the same
province and in the same district but were noncontiguous in order
to avoid program spillover. Despite efforts to select comparable
HZs, there were some key differences in the 2 zones, including
that the intervention HZ was more rural and depended heavily
on agriculture compared with the control HZ, which included
more urban areas and a wider range of sources of income. This
challenge was accommodated in lieu of selecting nonadjoining
HZs with similar demographics but risking substantial program
spillover from the intervention to the control HZ.
In the control HZ, the population received the usual standard
of care provided throughout the DRC based on the Essential
Nutrition Actions (ENA). The usual ENA standard of care
included the following: 1) iron–folic acid supplementation,
antimalarial medication, and individual IYCF counseling during
antenatal care visits; 2) individual counseling on IYCF and child
health by community health workers (CHWs) during clinic visits;
3) monthly group counseling on IYCF and child health and
growth promotion at health clinics; and 4) IYCF counseling
during health worker outreach clinics. In the intervention
zone, the enhanced IYCF–SQ-LNS/IMIKA program included
3 additional components, briefly as follows: 1) a nutrition
education campaign for mothers and pregnant women based
on the UNICEF community-based IYCF program tools, 2) the
introduction of SQ-LNS (Nutributter® formulation by Nutriset)
for daily consumption mixed into complementary foods among
children 6–12 mo of age, and 3) reinforcement of the role
of CHWs. Training for the enhanced IYCF–SQ-LNS program
was based on the UNICEF community-based IYCF program
tools with additional modules on the appropriate distribution,
storage, and use of SQ-LNS. Training sessions were implemented
using a cascade approach. Training for selected CHWs from
the HZs occurred at a central location (Lubumbashi). After
this, the trained CHWs went back to train other CHWs in
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their respective health area (aire de sante) within each HZ.
CHWs in the intervention area were provided with motor bikes
as both as an incentive and a way to improve their access
to remote communities. Motor bike distribution did not occur
in the comparison HZ. While both the intervention HZ and
the comparison HZ received counseling, the intervention HZ
included outreach counseling by CHWs on IYCF and SQ-LNS,
in addition to facility-based counseling, while the comparison
HZ received only facility-based counseling and no SQ-LNS
distribution or counseling. A full description of the enhanced
IYCF–SQ-LNS program is detailed elsewhere (27). Informed
consent was obtained from each mother/caregiver, and for
illiterate participants it was administered in the presence of
a literate adult household member. The Ministry of Health
and the National Statistics Office in Lubumbashi in DRC
reviewed and approved the protocol for the impact evaluation.
The University of Lubumbashi School of Public Health ethics
committee approved this evaluation.
Education and communication around the enhanced IYCF
and SQ-LNS
Before launching the program, formative research was con-
ducted on the acceptability, appropriate use, marketing, and
behavior change strategies needed to support the introduction
of an enhanced IYCF–SQ-LNS intervention. The formative
data collection included a month-long acceptability trial in
2010, which confirmed the SQ-LNS were well accepted (26).
Focus groups with caregivers of young children and key
informant interviews with mothers, fathers, and health workers
were conducted to develop product packaging and messaging
pertaining to the SQ-LNS and to assess the knowledge, attitudes,
practices, and barriers to optimal IYCF practices. The product
was locally branded as “Kulabora” in Swahili, which translates
to “eating better.”
The enhanced IYCF program had comprehensive counseling
and educational components that targeted all mothers and their
children (up to 12 mo of age) and pregnant women in the inter-
vention catchment area, but not the comparison HZ, as detailed
elsewhere (27). This was achieved by developing information,
education, and communication materials and messages and
tailored key messages, which were reinforced through various
channels in the intervention site. The 4 key messages were as
follows: 1) put your baby to the breast within an hour of giving
birth; 2) only give breast milk (no water or other foods) to
your baby until they are 6 mo of age; 3) from 6 mo of age,
continue to breastfeed and give solid foods enriched with fish,
caterpillars/insects, and eggs, even when you provide Kulabora;
and 4) wash your hands with soap or ash before preparing food,
eating, giving food to your baby, and after using the toilet.
These messages were included in flipchart teaching aids, during
educational sessions, other in-person interactions, on posters, on
the Kulabora packaging, and in radio spots.
The IMIKA program also strengthened the role of CHWs who
formed an integral part of IYCF counseling and, for SQ-LNS,
the monthly distribution, as well as counseling on the appropriate
storage and use of SQ-LNS. Mothers of children 6–12 mo of age
in the intervention zone were expected to receive 4 strips of 7
sachets of SQ-LNS (i.e., a monthly totaling 28 sachets, which
we refer to as a batch) at their nearest health facility during their
monthly clinic visits or for very-hard-to-access areas through
outreach services by health center staff. Each child was eligible
to receive 6 batches, 1/mo from 6–12 mo of age. Each of the 7
sachets detailed pictorially how to use SQ-LNS (Kulabora) and
included a key message: 1) give 1 packet per child per day, 2)
wash your child’s hands with soap and water before feeding, 3)
breastfeed your child before giving food, 4) put a small amount
of food that you think your child will eat in a separate bowl,
5) mix the Kulabora into the food, 6) feed the food mixed with
the Kulabora to your child, and 7) Kulabora is for children from
6 to 12 mo of age. In September 2012, the enhanced IYCF
counseling started, and Kulabora distribution started in May 2013
and continued until after the completion of all evaluation data
collection, ending approximately March 2015.
Lot-quality assurance survey assessments
Three rounds (February 2013, July 2013 and February 2014)
of lot-quality assurance surveys (LQASs) (28) were conducted in
all 13 health areas in the intervention zone. This was an additional
effort to monitor the enhanced intervention package put in place
to check if the program was functioning reasonably well before
going to the effort of conducting the endline survey. Health
areas/posts were graded on 21 benchmark questions that ranged
from SQ-LNS stocks, staff training, health worker activities,
program coverage in terms of SQ-LNS, and group counseling.
A pass or fail grade was assigned if a predefined coverage target
was achieved or not. Corrective action was implemented in low-
performing health centers as needed.
Program evaluation surveys
A pre-post, quasi-experimental effectiveness study design was
used to evaluate the IMIKA program. Repeated serial cross-
sectional baseline and endline surveys were conducted in the
intervention and the comparison HZs. The baseline survey was
conducted in October 2011 and the endline survey in October–
November 2014 in both sites. Caregivers of children 6.0–11.9 mo
of age were expected to receive monthly distributions of SQ-LNS
for a maximum of 6 distributions per child. The endline survey
occurred in October–November 2014, 6 mo prior to the end of
the SQ-LNS supply, which was expected to last until March
2015.
The baseline and endline surveys followed a 2-stage cluster-
sampling design. In the first stage, 30 clusters were randomly
selected from each HZ (60 total) using probability-proportional-
to-population-size sampling. The enumeration team made a list
of all children aged 6.0–17.9 mo in each selected cluster, and 22
children from each cluster were randomly selected. There was no
replacement for any reason. The same clusters were used for the
baseline and the endline data collection, but different households
and children were randomly selected, as the children selected
in the baseline sample had aged out of the intervention. The
estimated sample size provided 80% power to detect a relative
decline in the prevalence of anemia and ID of 15% and 20%,
respectively, at an ɑ of 0.05.
Study population, enrollment, and survey modules
The enhanced IYCF–SQ-LNS intervention was designed for
pregnant women and children aged <12 mo. However, the age
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range for the evaluation was children aged 6–18 mo, even though
those >12 mo would have aged out of the program. This was
done in order to reduce the difficulties and costs associated with
identifying enough children within a much narrower age band and
because the expectation was that any effects would persist among
those children who had aged out of the program. Due to cost, and
typical reduction in health care–seeking behavior of mothers of
children >1 y of age, it was not possible to expand the age range
of the intervention.
Trained enumerators asked caregivers questions pertaining
to household sociodemographic characteristics and knowledge,
attitudes, experiences, and behaviors relating to nutrition, IYCF,
anemia, and SQ-LNS. The enumerators asked mothers to recall
various breastfeeding practices for the selected child aged 6–18
mo, such as how soon after birth breastfeeding was initiated,
whether the child was breastfed yesterday, and when water and
complementary foods were first introduced. Also, at baseline and
endline, a 24-h recall of all the foods and drinks (including meals
and snacks) children consumed in the previous day and night was
collected in accordance with the standard WHO/UNICEF IYCF
indicators approach (29). In the endline survey only, mothers
were asked about exposure to specific parts of the IMIKA
program, such as familiarity with their CHW, participation in
group counseling sessions, and awareness of radio messages on
IYCF. Extensive information was also collected on the use of the
SQ-LNS, including how it was consumed (mixed or eaten alone),
if the child liked the SQ-LNS, any changes (both positive and
negative) since the child started consuming the SQ-LNS, and how
many monthly batches had been collected from the nearest health
facility.
Anthropometry and laboratory data
After the questionnaire was completed, anthropometric mea-
sures of the children were taken by trained enumerators
following standardized protocols (30). Weight was measured
using electronic Seca® 874 scales to the nearest 10 g. Length
was measured using a wooden Shorr® measuring board to the
nearest millimeter. Age was calculated using date of birth from
either a child health card or birth certificate (if available) and
the date of survey. If no reliable proof of age was available,
age was estimated in months using a local events calendar or by
mother/caregiver report.
A capillary blood specimen was collected in a 500-μL
Microtainer® with EDTA through a finger prick. One drop of
blood from the Microtainer® was used for the evaluation of
hemoglobin by the photometric method using the HemoCue®
301 hemoglobin system (HemoCue® AB). One drop was used
to test for malaria using a malaria antigen (HRP2/pLDH) combo
rapid test kit for Plasmodium falciparum and Plasmodium vivax.
The Microtainers® were stored in a cool box during the day
and transported to a central laboratory in each zone where
they were processed at the end of the day. The Microtainers®
were centrifuged at 3500 rpm for 10 min at room temperature
using a fixed-speed centrifuge, and the plasma was pipetted into
cryovial tubes and PCR tubes. The processed specimens were
then frozen and stored at −20◦C. At the end of the survey,
the specimens were shipped to Germany, where the VitMin
Laboratory used an ELISA to assess serum ferritin (SF), sTfR,
retinol binding protein (RBP), C-reactive protein (CRP), and ɑ1-
acid glycoprotein (AGP) (31).
Statistical data analyses
Descriptive statistics are presented as percentages. Statistical
significance was set at P < 0.05, and all analyses were
adjusted for clustering with Taylor series variance estimation.
Analyses were conducted with SAS version 9.4 (SAS Institute).
Child anthropometric variables were converted into z scores
[length-for-age (LAZ), weight-for-age (WAZ), and weight-for-
length (WLZ)] based on the WHO 2006 growth standards (32).
Biologically implausible values (BIVs; i.e., WAZ −6 < WAZ
> +5, LAZ −6 < LAZ > +5, WLZ −5 < WLZ > +5) were
flagged and excluded from subsequent analyses (32). Six BIVs
or 0.23% of observations were excluded. Key outcome measures
included anthropometric z-score indices (LAZ, WLZ, and WAZ)
and nutritional biomarkers (hemoglobin, SF, sTfR, and RBP).
Each outcome was assessed as a continuous variable as well as a
categorical indicator.
Anemia was defined according to WHO classifications as
anemic (hemoglobin <11.0 g/dL) and “severe or moderate
anemia” for hemoglobin <10.0 g/dL (33). Moderate and severe
anemia were combined to a single category due to the low
prevalence of severe anemia. All clusters in both HZs were
located <1000 m so hemoglobin concentration was not adjusted
for altitude. ID was defined as SF <12 μg/L. RBP concentrations
of less than the 0.7-μmol/L cutoff were used to define vitamin
A deficiency. SF, sTfR, and RBP biomarkers were adjusted
for inflammation using the Biomarkers Reflecting Inflammation
and Nutritional Determinants of Anemia (BRINDA) regression
correction technique (34–36).
We used an additive difference-in-difference (DiD) (37–39)
modeling technique to test and quantify program impact and
the associations between the integrated IYCF and SQ-LNS
and program indicators between the 2 HZs in pre- and post-
surveys. Generalized linear mixed models (GLMMs) with cluster
as a random effect were used to examine associations. The
DiD effects, their 95% CI, and P values were obtained from
GLMMs that accounted for HZ (intervention vs. control) and
time (endline vs. baseline) and included an interaction term
between HZ and time for quantifying program impact. This use
of DiD from mixed models to quantify program impact allowed
interpretation of average program effect for an average child
within each cluster and was well suited for our design of repeated
serial cross-sectional data of different children (38, 39). Two
separate GLMMs were used to explore these associations, i.e.,
1) continuous and 2) categorical variable outcome analysis.
It was determined a priori that the multivariable DiD models
would adjust for the following confounding covariates: child’s
sex and age; maternal age, education, and ethnicity; urban versus
rural; household’s primary source of income; household asset
tertile (from a cumulative count of all household possessions); the
presence of another child <5 y old in the household; and malaria
test positive status of the index child. Further, multivariate mixed
linear models were used to calculate prevalence differences (PDs;
%) for binary program indicators that were measured at endline
only in both HZs. Rao-Scott chi-square test was used to compare
differences in proportions for selected categorical indicators
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and a design-based t test was used for continuous variables as
appropriate.
Additionally, in the intervention HZ, program exposure also in-
cluded the SQ-LNS intervention component, which was captured
in a variety of indicators. Components included “mother received
SQ-LNS for her child at least once,” number of times SQ-
LNS received, and mothers who received 1 batch (28 SQ-LNS
sachets) at the last distribution, among several other variables.
We evaluated the potential dose–response effect of the SQ-LNS
among children 8 to 13 mo old in the intervention HZ who were
eligible to receive ≥3 monthly SQ-LNS distributions (3 × 28
sachets) and eligible to receive LNS within the last month.
This 8–13-mo age group was selected because SQ-LNS were
distributed during routine monthly health facility visits; however,
timely introduction of solid foods/complementary feeding at 6
mo in the villages in both HZs was low, ∼27% (27). Children
who were only 6 or 7 mo old would have had no or limited time
to consume SQ-LNS sachets as they would have received only 1
or 2 batch distributions at maximum, whereas children aged 13
mo would have recently finished SQ-LNS intake and have had a
high potential exposure to SQ-LNS over the prior 6 mo. Hence,
the 8–13-mo age range enabled us to identify a subpopulation of
children most likely to have sufficient program exposure to expect
a biological impact.
For this dose–response analysis we created 3 categories of
Kulabora exposure: 1) no SQ-LNS received, 2) low exposure
(received 1–2 batches of SQ-LNS), and 3) higher exposure for
≥3 mo of distribution of SQ-LNS batches, equivalent to ≥50%
of the total SQ-LNS sachets. GLMM was used to estimate relative
differences in program indicators across the 3 categories of
SQ-LNS exposure. In the intervention HZ, we also quantified
adjusted PDs of indicators between endline and baseline. We
note that adjusted prevalence or mean difference estimates were
all calculated from estimable functions of marginals (i.e., least-
square means) (40) that accounted for potential confounding
covariates. Therefore, estimates might not approximate the value
obtained from algebraic subtraction of crude differences in
prevalences (or means) and are also subject to missing covariates
in the full GLMM.
Results
Table 1 describes core characteristics of the surveys. There
were 1288 children included in the baseline survey and
1307 children in the endline survey. Participation rates were
high (>96%) and were similar across both HZs over time
(Figure 1). Less than one-third (30.6% baseline vs. 29.5%
endline) of control HZ mothers were <24 y old (younger
mothers), and in the intervention HZ this was 35.1% and 37.4%
at both time points. The proportion of younger children (6–11.99
mo) was not different between baseline and endline (46.1% to
50.8, P = 0.07) in the control or in the intervention HZ (57.2%
vs. 54.0%, P = 0.35). The proportion of male children was
lower at endline (53.2% vs. 47.9, P = 0.04) in the intervention
zone. In both zones, the proportion of mothers with incomplete
or no formal education significantly increased over the period
(control: 17% to 28.0%; P < 0.0001; intervention: 40.0% to
68.7%; P < 0.0001). Malaria prevalence increased markedly in
both the intervention (34.9 to 58.1%, P < 0.0001) and control
(8.2% to 24%, P < 0.0001) HZs over the 2 time points.
The results of selected program indicators (as percentages)
and adjusted DiD or PD analyses for categorical outcomes are
shown in Table 2. The proportion of mothers who received
prenatal care from a facility-based health worker during their last
pregnancy was significantly higher in percentage points (pp) in
the intervention than in the control HZ (+5.4 pp; 95% CI: 1.7, 9.2;
P < 0.01). Similarly, the program was significantly associated
with a higher proportion of mothers who knew their current CHW
in the intervention compared with the control HZ (multivariate
adjusted DiD: +47.8% points; 95% CI: 41.8, 53.8; P < 0.01).
Table 2 shows that the receipt of specific services provided by
the CHWs during the last pregnancy and birth of the index child
was significantly higher in the intervention than in the control
HZ. In the intervention HZ relative to the control HZ at endline,
a higher proportion of mothers (PD = +15.3 pp; P < 0.01) had
received breastfeeding information from a facility-based health
worker and had received counseling on child feeding from their
mobile CHWs (PD = +44.0%; P < 0.01). Similarly, in terms
of current or recent utilization of health services and exposure
to community programs, the intervention HZ was associated
with a significantly higher proportion of households with bednet
ownership (+7.7 pp), with children who slept under a bednet the
night prior to the survey (+18.2 pp), and of mothers who received
breastfeeding information from a health worker (+11.2 pp) and
from their CHWs (+44.0 pp) (P < 0.01, each PD).
The proportion of mothers who had heard of Kulabora (SQ-
LNS) was much higher in the intervention zone compared with
the comparison zone (PD: +95.0 pp; P < 0.01), which indicates
minimal spillover of the intervention. In the intervention zone,
70.5% of mothers had received ≥1 batch of SQ-LNS, and of
those, 99.6% reported feeding the SQ-LNS to their child at least
once. Of mothers who received their child’s SQ-LNS allotment,
92.8% reported mixing the SQ-LNS into their child’s food.
Among mothers of children aged 9–12 mo, 73% received the SQ-
LNS at least once, as did 60.3% of mothers with children aged
6.0–8.9 mo. Mothers of children aged 12.0–17.9 mo received an
average of 2.7 batches, out of an expected 6 batches (1/mo from 6
to 12 mo). Among the mothers who reported receiving SQ-LNS
1 mo prior to the endline survey date, 91.3% reported receiving
the expected 28 sachets per batch. Among mothers who had
received their monthly SQ-LNS allotment (28 sachets) at the last
monthly distribution (91.3%), 74.7% of those mothers reported
that their child consumed all 28 sachets. The mean number of
sachets consumed from the last distribution was 24.7 per child.
Results of program impact estimates of child growth and
micronutrient indicators from baseline to endline are shown
in Table 3. With the exception of hemoglobin concentrations,
there were no significant program impacts (DiDs) in continuous
growth and nutritional biomarker outcomes. Compared with
baseline estimates, the mean hemoglobin concentration was
lower in the endline survey in both zones. However, the decline in
hemoglobin concentrations was smaller in the intervention zone
than in the comparison zone, and the multivariate adjusted DiD
in hemoglobin was significant (0.26 g/dL; P = 0.02).
While the prevalence of anemia increased in both zones
between the baseline and endline surveys, the increase was
significantly less in the intervention zone [64.8% to 72.2%
(+7.4%) vs. 32.1% to 48.7% (+16.6%) in the comparison zone].
Further, in the multivariate DiD model, the IMIKA program was
associated with a −11.0% (P = 0.003) adjusted change in the
prevalence of any anemia. Similarly, there was also a significant
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TABLE 1 Demographic characteristics of children 6–18 mo of age in the baseline and endline surveys in 2 health zones (control and intervention) in
Katanga Province, Democratic Republic of Congo











Urban 317 (49.7) 332 (50.8) 108 (16.6) 107 (16.4)
Rural 321 (50.3) 321 (49.2) 542 (83.4) 547 (83.6)
Primary source of income
Agriculture 234 (36.7) 258 (39.5) 530 (81.5) 536 (82.0)
Wage labor/daily work 209 (32.8) 248 (38.0) 56 (8.6) 85 (13.0)
Other 195 (30.6) 147 (22.5) 64 (9.9) 33 (5.1)
Asset tertile1
Tertile 1 (most assets) 349 (54.7) 298 (46.4) 81 (12.5) 114 (17.6)
Tertile 2 150 (23.5) 176 (27.4) 286 (44.0) 264 (40.8)
Tertile 3 (fewest assets) 139 (21.8) 169 (26.3) 283 (43.5) 269 (41.6)
Number of children <5 y in the household
Only the index child 135 (21.2) 147 (23.3) 178 (27.4) 221 (34.1)
Two or more children <5 y 503 (78.8) 483 (76.7) 472 (72.6) 427 (65.9)
Maternal characteristics
Mother’s age
Youngest tertile (<24 y) 195 (30.6) 191 (29.5) 227 (35.1) 243 (37.4)
Middle tertile (24–30 y) 227 (35.6) 230 (35.5) 201 (31.1) 185 (28.5)
Oldest tertile (>30 y) 216 (33.9) 227 (35.0) 218 (33.8) 222 (34.2)
Highest level of education achieved
Incomplete/no formal education 108 (17.0) 183 (28.0) 260 (40.0) 449 (68.7)
Primary school 309 (48.5) 330 (50.5) 329 (50.6) 168 (26.7)
Secondary school or university 220 (34.5) 140 (21.4) 61 (9.4) 37 (5.7)
Maternal report of location for primary health care
Hospital 64 (10.0) 55 (8.4) 81 (12.5) 55 (8.4)
Health center 456 (71.5) 552 (84.5) 431 (66.3) 493 (75.4)
Health post 118 (18.5) 46 (7.0) 138 (21.2) 106 (16.2)
Child characteristics
Child’s sex
Male 334 (52.4) 328 (50.2) 346 (53.2) 313 (47.9)
Child’s age (6–17.99 mo)
6–11.99 mo 294 (46.1) 332 (50.8) 372 (57.2) 353 (54.0)
Child’s ethnicity
Bemba 75 (11.8) 87 (13.3) 600 (92.3) 592 (90.5)
Other2 563 (88.2) 566 (86.7) 50 (7.7) 62 (9.5)
Child’s malaria status at time of survey3
Positive test for malaria 52 (8.2) 157 (24.0) 227 (34.9) 380 (58.1)
1Based on a principal components analysis of household asset ownership including whether the household has a radio, television, mobile phone,
refrigerator, stove, chair, bed, lamp, oven, hoe, sewing machine, bicycle, car, truck, and electricity.
2Other ethnicities include Luba, Balamba, Basanga, Rund, Hemba, Tabwa, Kasai, Kaonde, and Katshowe.
3Child was tested for malaria using a rapid test kit.
potential program association with moderate or severe anemia,
with a DiD of −6.5% (P = 0.04).
We examined SQ-LNS dose–response in analyses from the
endline survey in the intervention zone only among children 8–13
mo of age (Table 4). Children who received ≥3 mo of SQ-LNS
batch distributions had a significantly higher adjusted mean LAZ
(+0.40, P = 0.03), WAZ (+0.37, P = 0.04), and hemoglobin
concentration (+0.65 g/dL, P = 0.007) than children who did
not receive SQ-LNS in the full multivariable models. Children
in the higher SQ-LNS category had a significant lower adjusted
prevalence of stunting (PD = −16.7%; P = 0.03). Supplemental
Table 1 describes intervention arm–specific results for nutrition
indicators. In sensitivity analyses (Supplemental Table 2), we
found that mean ferritin concentrations in both intervention and
control HZs and at both time points were significantly higher
in malaria-positive compared with malaria-negative children.
In contrast, hemoglobin concentrations were lower among
malaria-positive children. This was consistent with the results of
multivariate regression analyses (Supplemental Table 3). Here,
malaria was positively associated with anemia [prevalence ratio
(PR): 1.65; 95% CI: 1.52, 1.79] and iron deficiency anemia (PR:
1.28; 95% CI: 1.15, 1.43) but inversely associated with ID (PR:
0.61; 95% CI: 0.53, 0.70).
Discussion
In this pre- and post-survey quasi-experimental effectiveness
design in 2 HZs in the DRC, children aged 6–18 mo in an
integrated IYCF–SQ-LNS intervention HZ experienced signifi-
cantly smaller increases in the prevalence of anemia relative to
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FIGURE 1 Participant flow diagram and survey response rates across 2 health zones in Katanga Province, Democratic Republic of Congo. ∗children were
considered unavailable if they were not available in their household after three attempted visits.
a comparison HZ and experienced significantly smaller declines
in mean hemoglobin. Regardless of program arm, there was
no impact on child growth indicators (stunting, wasting, and
underweight). However, in the as-treated analyses, we observed
an SQ-LNS biological dose–response in the intervention HZ
at endline among children aged 8–13 mo, such that children
with higher program exposure (receipt of ≥3 monthly batches
of SQ-LNS) showed improvements in growth (LAZ, WAZ),
lowered PD of stunting, and higher hemoglobin compared with
children with no receipt of SQ-LNS. This evaluation is one of
the first to examine the effectiveness of SQ-LNS integrated with
an enhanced IYCF program and delivered within an existing
community-based public health care system. The stand-alone
impact of SQ-LNS on growth in various RCTs has been mixed,
with studies in Bangladesh and Ghana showing a positive impact
on child growth (17, 19), whereas similar studies in Malawi
and Peru did not (22, 41). Nutrition education to improve
IYCF practices has previously been shown to decrease stunting
prevalence in children (6), but program impact may be context
specific, particularly in settings where food access is not a
limiting factor (6). Similarly, evidence from systematic review
and meta-analyses of longitudinal trials from low- to middle-
income countries found a small but significant positive associ-
ation between complementary feeding with nutrition education
interventions on child growth indicators in food-secure settings
(42).
Given that per protocol analyses showed a positive impact in
the DRC, this suggests that, on average, all children might not
have received SQ-LNS monthly or the other components [e.g.,
wash, sanitation, and hygiene (WASH), counseling messages, or
increased contacts with health service] and hence it is possible
that, with improved program fidelity, the IYCF–SQ-LNS package
may demonstrate greater effectiveness and impact at scale.
Despite improvements in certain aspects of IYCF, there were very
few changes in dietary indicators, such as dietary diversity (27),
implying that even if products like SQ-LNS are available, efforts
to improve the quality of locally available complementary foods,
increasing dietary diversity, and food security should remain a
priority.
Prior studies in other countries that provided SQ-LNS to
mothers in pregnancy and to their infants (after 6 mo) had positive
effects on growth (17, 19). SQ-LNS during pregnancy might
avert adverse birth events like small-for-gestational age, low birth
weight, and preterm birth, which can negatively impact growth
indicators in childhood (43), as faltered growth trajectories
are usually set in utero (44), especially in low- and middle-
income countries. The current IYCF–SQ-LNS program gave
children daily SQ-LNS only for a limited duration of 6 mo,
and their mothers did not receive SQ-LNS during pregnancy
(they did receive iron and folic acid supplements and malaria
prophylactics). Considering the results in the broader literature,
further exploration of the optimal timing of SQ-LNS might be an
important area for future efficacy and effectiveness research. It is
possible that the observed positive impact on child growth in the
DRC might have been larger if mothers of these children had been
given counseling plus SQ-LNS during pregnancy. The causes
of child growth faltering are multifactorial, complex, and driven
by both biological and contextual factors (water and sanitation,
infectious diseases, poverty) (44–46), which might have been
stronger in these rural HZs of Katanga Province, thereby limiting
the overall impact of the IYCF–SQ-LNS package to improve
other child growth indicators. Since this research is based on an
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adjusted DiD (95% CI) P
Continuous outcomes
LAZ − 1.51 ± 0.07 − 1.49 ± 0.07 − 1.92 ± 0.06 − 2.05 ± 0.06 − 0.11 (−0.30, 0.08)3 0.26
WLZ − 0.13 ± 0.04 − 0.36 ± 0.04 − 0.56 ± 0.04 − 0.71 ± 0.04 +0.11 (−0.07, 0.28)3 0.24
WAZ − 0.89 ± 0.06 − 1.05 ± 0.06 − 1.47 ± 0.05 − 1.64 ± 0.05 +0.03 (−0.15, 0.21)3 0.77
Hemoglobin, g/L 11.31 ± 0.07 10.83 ± 0.07 10.13 ± 0.08 9.83 ± 0.08 +0.26 (0.04, 0.48)3 0.02
Serum ferritin,4 μg/L 11.06 ± 0.96 14.28 ± 0.96 13.42 ± 0.71 16.53 ± 0.71 − 0.57 (−2.77, 1.63)3 0.61
sTfR,4 μg/L 9.30 ± 0.21 9.78 ± 0.21 10.34 ± 0.26 11.51 ± 0.25 +0.49 (−0.36, 1.35)3 0.25
RBP,4 μmol/L 1.16 ± 0.02 1.2 ± 0.02 1.23 ± 0.02 1.29 ± 0.02 +0.02 (−0.05, 0.08)3 0.60
Categorical outcomes
Stunting5 215 (33.8) 208 (32.1) 328 (50.6) 330 (50.5) +0.0% (−7.3, 7.5)6 0.98
Wasting5 31 (4.9) 42 (6.5) 62 (9.6) 80 (12.2) +0.7% (−3.6, 5.0)6 0.75
Underweight5 99 (15.5) 116 (17.9) 203 (31.3) 238 (36.4) +1.8% (−4.9, 8.4)6 0.60
Anemia7 205 (32.1) 318 (48.7) 421 (64.8) 472 (72.2) − 11.0% (−18.1, −3.8)6 <0.01
Moderate or severe anemia7 68 (10.7) 142 (22.0) 251 (38.6) 305 (36.7) − 6.5% (−12.8, −0.2)6 0.04
Serum ferritin <12 μg/L4 459 (71.9) 411 (62.9) 356 (54.8) 294 (45.0) +1.7% (−5,5, 8.9)6 0.64
sTfR >8.3 μg/L4 322 (50.5) 276 (42.3) 381 (58.6) 389 (59.5) +5.9 (−1.7, 13.5)6 0.13
Iron deficiency4,8 504 (79.0) 486 (74.4) 522 (80.3) 501 (76.6) +0.04% (−6.1, 6.9)6 0.90
Iron deficiency anemia4,8 169 (26.5) 212 (32.5) 215 (33.1) 213 (32.6) − 5.4% (−12.5, 1.8)6 0.14
Vitamin A deficiency4,9 26 (4.1) 30 (4.6) 39 (6.0) 27 (4.1) − 2.6% (−6.0, 0.7)6 0.12
1Values are means ± SEs or n (%) unless otherwise indicated. BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia;
DiD, difference-in-difference; LAZ, length-for-age z score; RBP, retinol binding protein; sTfR, soluble transferrin receptor; WAZ, weight-for-age z score;
WLZ, weight-for-length z score.
2Fully adjusted multivariable models controlled for child’s sex, age, and ethnicity; maternal age and education; whether the household was urban or
rural; the household’s primary source of income and asset tertile; whether there was another child <5 y in the household; and whether the child tested positive
for malaria.
3For continuous outcome variables: adjusted difference in mean differences and corresponding 95% CIs and P values were obtained from mixed linear
regression models with an interaction term between health area (intervention vs. control) and time (endline vs. baseline) and cluster as a random effect.
4Biomarkers are adjusted for inflammation using the BRINDA linear regression technique described in Suchdev (48).
5Stunting, wasting, and underweight defined as <2 SDs for LAZ, WLZ, and WAZ, respectively.
6For categorical outcomes: adjusted DiD, DiD for proportions (%), their 95% CIs, and P values were obtained from mixed linear models with an
interaction term between health zone (intervention vs. control) and time (endline vs. baseline) and cluster as a random effect.
7Anemia defined as hemoglobin <11 g/dL.
8Iron deficiency defined as serum ferritin <12 μg/L. Iron deficiency anemia is defined as iron deficiency + anemia (hemoglobin <11 g/dL).
9Vitamin A deficiency defined as RBP <0.70 μmol.
integrated program, the observed associations are likely due to
the combined effect of all components and not necessarily due to
a single component, and the evaluation was not designed to tease
out the effects of different components. Nonetheless, the findings
suggest that a similar integrated approach and program delivery
might be beneficial in other settings.
The integrated program was associated with a significantly
lower increase in the proportion of children who suffered from
anemia and consistent with data from a similar integrated health
system SQ-LNS program in Peru, which saw an increased
hemoglobin and reduced anemia prevalence (22). The DRC
study, however, found no impact on other micronutrient status
indicators, such as ID, iron deficiency, anemia, or vitamin A de-
ficiency. This suggests that the inverse program association with
anemia may be due to the interplay among program effectiveness
of the other intervention components and sociodemographic and
biological factors. Although it has been thought that 50% of
anemia is attributable to ID in many settings (47), it is possible
that anemia in this population is less likely to be due to ID.
Inflammation has been shown to be related to biomarkers of iron
and vitamin A. All models used inflammation corrected (34–36)
SF, RBP, and sTfR data, likely reducing the role of inflammation
in our interpretation. It is also possible that the observed increase
in hemoglobin could be due to improvements in vitamin B-12,
folate, and vitamin C status and other nutrients in the SQ-LNS
formulation, which were not assessed in this evaluation.
There were marked increases in malaria prevalence across
the 2 surveys and in both HZs, even though the surveys were
conducted in the same season of 2011 and 2014. Malaria was
assessed with qualitative rapid test kits but not by parasitic
load and there could still be residual confounding, even after
controlling for malaria in our models. This might also partially
explain the nonsignificant ID impact. This is because malaria-
positive children had higher SF concentrations relative to
malaria-negative peers and could be due to iron sequestration
during malaria infection (49–51). Children in the intervention
HZ who received ≥3 mo of SQ-LNS distributions versus no
SQ-LNS had a higher hemoglobin (adjusted mean difference:
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TABLE 4 Dose–response comparisons based on the number of times the mother received LNSs for her child, among children 8–13 mo old in the
postintervention survey in the intervention health zone, Katanga Province, Democratic Republic of Congo1
Received LNSs 1–2 times (n = 136) Received LNSs of ≥3 batch distributions (n = 80)
Adjusted multivariate2 model Adjusted multivariate2 model
Continuous outcomes
No LNSs (ref
category) (n = 89) Values
Adjusted mean
difference or adjusted
PD, % (95% CI) P Values
Adjusted mean
difference or adjusted
PD, % (95% CI) P
Anthropometry
LAZ − 2.17 ± 0.11 − 2.06 ± 0.12 0.08 (−0.24, 0.41)3 0.61 − 1.99 ± 0.14 0.40 (0.02, 0.78)3 0.04
WLZ − 0.84 ± 0.11 − 0.69 ± 0.1 0.16 (−0.14, 0.45)3 0.29 − 0.67 ± 0.11 0.18 (−0.16, 0.53)3 0.30
WAZ − 1.83 ± 0.11 − 1.67 ± 0.09 0.16 (−0.14, 0.46)3 0.29 − 1.56 ± 0.12 0.37 (0.02, 0.72)3 0.04
Nutritional biomarkers
Hemoglobin, g/dL 9.37 ± 0.22 9.46 ± 0.16 − 0.02 (−0.43, 0.39)3 0.92 10.2 ± 0.18 0.65 (0.18, 1.12)3 <0.01
Serum ferritin,4 μg/L 14.15 ± 1.37 14.8 ± 1.45 1.91 (−1.83, 5.64)3 0.3154 13.89 ± 1.3 − 0.46 (−4.79, 3.86)3 0.83
sTfR,4 μg/L 13.52 ± 0.94 12.25 ± 0.67 − 1.27 (−3.21, 0.68)3 0.20 11.59 ± 0.65 − 1.71 (−3.97, 0.56)3 0.14
RBP,4 μmol/L 1.24 ± 0.04 1.32 ± 0.04 0.09 (−0.02, 0.21)3 0.12 1.23 ± 0.04 − 0.02 (−0.15, 0.12)3 0.82
Nutrition indicators, n (%)
Stunting5 51 (57.3) 64 (47.1) − 9.3 (−22.6, 3.9)6 0.17 40 (50.0) − 16.7 (−32.1, −1.2)6 0.03
Wasting5 14 (15.7) 17 (12.5) − 3.7 (−12.7, 5.3)6 0.42 6 (7.5) − 9.0 (−19.5, 1.6)6 0.09
Underweight5 37 (41.6) 46 (33.8) − 8.1 (−21.0, 4.8)6 0.22 27 (33.8) − 14.3 (−29.4, 0.8)6 0.06
Anemia7 70 (78.7) 108 (79.4) +2.5 (−8.7, 13.8)6 0.66 52 (65.0) − 12.2 (−25.4, 0.9)6 0.07
Moderate or severe anemia7 49 (55.1) 73 (53.7) − 1.2 (−10.7, 13.2)6 0.84 32 (40.0) − 12.6 (−26.5, 1.3)6 0.08
Serum ferritin <12 μg/L4 45 (50.6) 66 (48.5) − 3.7 (−17.3, 9.8)6 0.59 41 (51.3) − 3.1 (−18.8, 12.6)6 0.70
sTfR >8.3 μg/L4 56 (62.9) 88 (64.7) +3.2 (−9.6, 16.0)6 0.629 52 (65.0) +0.1 (−14.9, 15.2)6 0.98
Iron deficiency anemia4,8 36 (40.5) 52 (38.2) − 4.6 (−18, 8.8)6 0.50 26 (32.5) +7.0 (−8.6, 22.7)6 0.38
Vitamin A deficiency4,9 8 (9.0) 5 (3.7) − 4.9 (−11.1, 1.2)6 0.1126 2 (2.5) − 6.2 (−13.3, 1.0)6 0.08
1Values are means ± SEs unless otherwise indicated. SEs around means have taken clustering into account. Analysis is restricted to children aged 8–13 mo since children <8
mo would not have been old enough to have received LNSs of ≥3 batch distributions and children >13 mo should not have received SQ-LNS within the last month. BRINDA,
Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; DiD, difference-in-difference; GLMM, generalized mixed linear regression model; LAZ,
length-for-age z score; LNS, lipid-nutrient supplement; PD, prevalence difference; RBP, retinol binding protein; ref, reference; SQ-LNS, small-quantity lipid-nutrient supplements;
sTfR, soluble transferrin receptor; WAZ, weight-for-age z score; WLZ, weight-for-length z score.
2Fully adjusted multivariable models controlled for child’s sex, age, and ethnicity; maternal age and education; whether the household was urban or rural; the household’s
primary source of income and asset tertile; whether there was another child <5 y in the household; and whether the child tested positive for malaria infection.
3For continuous outcome variables: adjusted mean differences and 95% CIs were obtained from GLMMs with cluster as a random effect.
4Biomarkers are adjusted for inflammation using the BRINDA linear regression technique described in references 34–36.
5Stunting, wasting, and underweight defined as <2 SDs for LAZ, WLZ, and WAZ, respectively.
6Adjusted PDs are estimated from mixed models for binary outcome with the identity link and cluster as a random effect and using no SQ-LNS as a referent category.
Adjusted PDs are estimated from predicted population marginals with adjustment for covariates (47) but not from algebraic subtraction. Adjusted PD and adjusted mean difference
estimates might not approximate values obtained from algebraic subtraction of crude prevalences and are subject to missing covariates in the GLMM.
7Anemia defined as hemoglobin <11 g/dL; moderate or severe anemia as hemoglobin <10 g/dL.
8Iron deficiency is defined as serum ferritin <12 μg/L. Iron deficiency anemia is defined as iron deficiency + anemia (hemoglobin <11 g/dL).
9Vitamin A deficiency is defined as RBP <0.70 μmol.
+0.65 g/dL) and lower stunting (adjusted PD: −16.7%) in
the as-treated-analyses. This suggests that the IYCF–SQ-LNS
program can achieve impact in settings like the DRC, but
low program intensity/adherence might have been a major
bottleneck to biological impact, as was noted elsewhere in a
Gambian RCT (52). For example, at endline, >44% of mothers
in the intervention HZ reported they received information on
breastfeeding from a CHW and counseling on child feeding from
a CHW (≤0.5% did so for each in the comparison HZ).
Strengths of this study include use of a comparison group
and DiD analysis in a context where it was not possible to
carry out a prospective, longitudinal study of mother–child pairs.
Both surveys were conducted at similar times of the year,
alleviating the potential role of seasonality. We were unable
to assess fidelity or quality of other program components such
as WASH, counseling messages, or maternal contacts with the
health services. Clinical outcomes and morbidity data were
not assessed in this work and might be a potential limitation.
However, the possibility that improvements in hemoglobin
concentrations or anemia reductions could impact functional
outcomes is plausible in this DRC sample of young children. The
evaluation design involved repeated cross-sectional surveys, so
we are unable to tease out cohort or demographic differences
or a temporal sequence of events. We could not directly assess
and statistically account for SQ-LNS intake/adherence and
implementation difficulties due to security issues. Children aged
≥6 mo or those for whom complementary feeding was delayed
would not have been exposed to the SQ-LNS component. In
anticipation of these recruitment challenges in identifying enough
children, it was decided a priori that children aged 12–18 mo
would also be sampled, and this might have affected the effective
dosing duration received by certain groups of children. As child
age was adjusted for in our models, it is less likely this sampling
frame might have systematically biased our findings. If anything,
it would have led to a dilution of overall impact because some
children would not have consumed SQ-LNS for several (≤6)
months prior to the endline data collection. An LQAS was
conducted in the intervention HZ as part of routine program
monitoring. Even though it was not an additional intervention
we do recognize that it was higher intensity and included
additional resources than standard monitoring practice. A mine
was reopened in Kipushi (control HZ) between baseline and
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endline, which may potentially have contributed to changes in
the economic status of families, but we are unable to statistically
control for these potential confounders and any impact they
might have (e.g., food availability, household food insecurity,
environmental conditions) in the catchment area.
Maternal recall bias of breastfeeding practices could be a
limitation, but it is possible that this would have occurred
similarly in both HZs. We are unsure if recall bias had any
impact on observed associations and, if so, the potential direction.
Although we attempted to adjust using multivariate models
with key sociodemographic characteristics and for several other
potential confounding factors, residual confounding is still
possible.
In conclusion, the integrated IYCF–SQ-LNS program imple-
mented through the public health care platform in an intervention
zone of 1 province of the DRC was associated with a significantly
smaller increase in anemia and smaller declines in hemoglobin,
but there was no effect on anthropometric indicators. Children
aged 8–13 mo in the intervention zone who received ≥3
mo of SQ-LNS distributions had higher LAZ, WAZ, and
hemoglobin and a lower prevalence of stunting compared with
those who did not, highlighting the importance of program
adherence and biological impact. Future research could consider
exploration of contextual tools that could maximize coverage
and intake adherence in programs integrating an IYCF–SQ-LNS
intervention.
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